Bloom Public Health partners Cameroon’s drug regulator to boost pharmaceutical industry

Bloom Public Health, which is a technical partner of the National Institute for Pharmaceutical Research and Development (NIPRD) Abuja, and other institutions in Africa, has announced that she is extending her African footprint and opening a new office in Yaoundé, Cameroun to accommodate its ease of operations in the country and to better meet its obligations to the Ministry of Public Health.

Chief Executive Officer (CEO), Bloom Public Health, Prof. Chimezie Anyakora, at a press conference, yesterday, said plans to develop operations in Yaoundé, Cameroun were initiated by Bloom Public Health and the National Drug Quality Control and Valuation Laboratory (LANACOME’s) previous signed Memorandum of Understanding (MoU) and the promising development of Cameroun’s public health system. Anyakora, who is a pharmaceutical chemist, said the new office, which will include experts from the Cameroun region, would be the company’s second African office. “Bloom’s presence in Cameroun aims to support the Ministry of Public Health in capacity building, strengthening of regulatory activities, development of a post-marketing surveillance system, and other functions. The new office will allow Bloom Public Health to operate seamlessly in the Central African region,” he said.

Anyakora added: “The opening of Bloom Public Health’s new Yaoundé office is an important step in realizing our goal of achieving better healthcare in Africa. The new office shows our commitment to ensure a sustainable plan to solve African public health issues rather than just an intervention.”

The new office is meant to commence operations immediately; it will primarily handle activities in the Central African region.

The Director-General, LANACOME, Dr. Ngono Rose Mballa, expressed her joy at the commitment of Bloom Public Health to supporting the Cameroun Public Health system and pledged her support to aid Bloom activities in ensuring that the Cameroun pharmaceutical industry experiences positive development. “Early, in April 2020 Bloom Public Health announced the collaboration and advancement of its operations in Cameroon, with the signing of a Memorandum of Understanding with the National Drug Quality Control and Valuation Laboratory and during the press conference at Lanacome, reestablished their commitments by renewing the MoU signed last year,” Mballa.

Anyakora added: “Bloom Public Health concept was born from the need to create strategic and operational solutions at the African level for public health problems, and particularly in the pharmaceutical sector. For more information, visit www.bloompublichealth.com.”